TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RYTM

Rhythm Pharmaceuticals Inc

Healthcare · Biotechnology

98.70$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Rhythm Pharmaceuticals Inc (RYTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 437 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RYTM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
354 333 259 382 364 392 387 373 507 480 442 437
329 308 236 357 340 374 369 361 495 467 430 427
65 60 53 162 48 89 106 136 52 54 62 66
299 276 201 319 298 321 314 291 416 389 341 331
15 15 15 18 19 19 18 26 33 26 34 40
7.8 8.6 8.5 12 14 19 19 19 22 26 29 31
7.2 7.0 6.8 6.6 6.4 6.2 6.0 5.7 5.5 5.3 5.1 4.9
157 163 197 202 211 228 224 239 211 210 205 220
50 55 54 55 98 116 112 129 104 106 103 124
0.7 0.8 0.8 0.8 – – 0.2 0.5 0.6 0.7 0.7 0.7
3.8 4.9 7.6 4.5 4.9 12 12 16 14 14 12 16
197 170 62 179 153 165 163 134 296 270 238 217
-853 -895 -1,036 -1,068 -1,112 -1,155 -1,205 -1,251 -1,304 -1,352 -1,408 -1,457
58 59 60 61 61 62 63 64 64 67 68 69

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?